Biochemical Contamination
Steris, U.S. Army, enter R&D collaboration
Published in TB and Outbreaks Week, September 3rd, 2002
Steris Corp. (STE) announced that its subsidiary, Strategic Technology Enterprises, Inc., and the United States Army Edgewood Chemical Biological Center (ECBC) have entered into an agreement to conduct a collaborative research and development project to evaluate, optimize, and modify Steris's Vaporized Hydrogen Peroxide (VHP) technology, and demonstrate its effectiveness against biological and chemical warfare agents (BWA/CWA).
Strategic Technology Enterprises will provide technical and decontamination expertise in VHP technology and VHP related equipment. ECBC will provide chemical activation technology and BWA/CWA testing facilities for conducting research to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Food-borne Illness
First drug developed for widespread use against botulism - Tuberculosis Therapy
Salicylate agents impair antimicrobial drug efficacy - Infectious Disease Vaccine
VSV-based vaccine may protect against papillomavirus - Polio
UNICEF targets over 1 million Afghan children for immunization - Tuberculosis Therapy
Gender, AIDS status do not affect isoniazid levels - Vaccine Development
Efficacy of tuberculosis vaccine increased by formulation with a cationic colloid - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
